Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short ZDV Course to Prevent Perinatal HIV in Thailand
NCT00386230Phase 3Completed
- Sponsor
- Institut de Recherche pour le Développement
- Start
- Jun 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of zidovudine in human immunodeficiency virus infection (HIV) (4 arms), sponsored by Institut de Recherche pour le Développement. Primary endpoint: Definitive HIV infection in children. Started Jun 1997; status: completed.
02
Drugs
zidovudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00386230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00386230.